Drug · DIN 02413019
CELECOXIB
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 24, 2014.
- Drug Identification Number (DIN)
- 02413019
- Company (DIN owner)
- Alembic Pharmaceuticals LimitedVadodara, Gujarat, India
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Celecoxib M01AH01
- Class
- Human
- Record last updated
- July 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CELECOXIB | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 24, 2014: NOC 16337Abbreviated New Drug Submission (ANDS)
Other DINs named CELECOXIB
- DIN 02424371 · Marketed
- DIN 02424398 · Marketed
- DIN 02429675 · Marketed
- DIN 02429683 · Marketed
- DIN 02436299 · Marketed
- DIN 02436302 · Marketed
- DIN 02384299 · Cancelled Pre Market
- DIN 02384302 · Cancelled Pre Market
- DIN 02413027 · Approved
- DIN 02436868 · Cancelled Pre Market
- DIN 02436876 · Cancelled Pre Market
- DIN 02477661 · Cancelled Post Market
- DIN 02477688 · Cancelled Post Market